• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
HU Mengyue, LIU Can, ZHANG Mian, HU Nan, LIU Li, LIU Xiaodong. Alteration of cytochrome P450s activity under diabetic conditions and its impact on the development of diabetes mellitus[J]. Journal of China Pharmaceutical University, 2014, 45(2): 153-160. DOI: 10.11665/j.issn.1000-5048.20140204
Citation: HU Mengyue, LIU Can, ZHANG Mian, HU Nan, LIU Li, LIU Xiaodong. Alteration of cytochrome P450s activity under diabetic conditions and its impact on the development of diabetes mellitus[J]. Journal of China Pharmaceutical University, 2014, 45(2): 153-160. DOI: 10.11665/j.issn.1000-5048.20140204
shu

Alteration of cytochrome P450s activity under diabetic conditions and its impact on the development of diabetes mellitus

More Information
    Graphical Abstract
    • Abstract
  • Cytochrome P450s(CYP450s)is one of the most important phase-I drug-metabolizing enzyme family that participates in the metabolism of most clinical drugs in liver and intestine. Accumulative evidences have reported that the activities and expressions of hepatic CYP450s exhibited significant alterations under diabetic condition. This article summarizes the induction or inhibition of different isoforms of CYP450s, including CYP3A, CYP2E1 and CYP1A2, in clinical or experimental diabetic conditions, and analyzes the impact of species difference, types and progression of diabetes on CYP450s activity. The article further lists the altered pharmacokinetic behaviors as well as adverse drug effects due to alteration of CYP450s in reported diabetic cases. The correlations between the altered metabolism of endocrines, the aggravation of insulin resistance, and the alteration of CYP450s activity are illustrated to shed more light on the pathogenesis of diabetes.
    • FullText(HTML)
    • References (74)
  • [1]
    Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030[J].Diabetes Res Clin Pract,2010,87(1):4-14.
    [2]
    Xu Y,Wang L,He J,et al.Prevalence and control of diabetes in Chinese adults[J].JAMA,2013,310(9):948-959.
    [3]
    Eaton WW.Epidemiologic evidence on the comorbidity of depression and diabetes[J].J Psychosom Res,2002,53(4):903-906.
    [4]
    Groot M,Anderson R,Freedland KE,et al.Association of depression and diabetes complications:a meta-analysis[J].Psychosom Med,2001,63(4):619-630.
    [5]
    Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38.UK prospective diabetes study group[J].BMJ,1998,317(7 160):703-713.
    [6]
    Wolf G,Müller N,Mandecka A,et al.Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus[J].Clin Nephrol,2007,68(2):81-86.
    [7]
    Gwilt PR, Nahhas RR, Tracewell WG. The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans[J].Clin Pharmacokinet,1991,20(6):477-490.
    [8]
    Martignoni M,Groothuis GM,de Kanter R.Species differences between mouse,rat,dog,monkey and human CYP-mediated drug metabolism,inhibition and induction[J].Expert Opin Drug Metab Toxicol,2006,2(6):875-894.
    [9]
    Shimada T,Yamazaki H,Mimura M,et al.Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs,carcinogens and toxic chemicals:studies with liver microsomes of 30 Japanese and 30 Caucasians[J].J Pharmacol Exp Ther,1994,270(1):414-423.
    [10]
    Thummel KE,Wilkinson GR.In vitro and in vivo drug interactions involving human CYP3A[J].Annu Rev Pharmacol Toxicol,1998,38:389-430.
    [11]
    Dostalek M,Court MH,Yan B,et al.Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus[J].Br J Pharmacol,2011,163(5):937-947.
    [12]
    Moisés EC,Duarte Lde B,Cavalli Rde C,et al.Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus[J].Eur J Clin Pharmacol,2008,64(12):1 189-1 196.
    [13]
    Hu N,Xie S,Liu L,et al.Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats[J].Drug Metab Dispos,2011,39(3):419-425.
    [14]
    Hasegawa Y,Kishimoto S,Shibatani N,et al.Effects of insulin on CYP3A activity and nicardipine disposition in streptozotocin-induced diabetic rats[J].J Pharm Pharmacol,2010,62(7):883-889.
    [15]
    Chen GM,Hu N,Liu L,et al.Pharmacokinetics of verapamil in diabetic rats induced by combination of high-fat diet and streptozotocin injection[J].Xenobiotica,2011,41(6):494-500.
    [16]
    Oh SJ,Choi JM,Yun KU,et al.Hepatic expression of cytochrome P450 in type 2 diabetic Goto-Kakizaki rats[J].Chem Biol Interact,2012,195(3):173-179.
    [17]
    Kudo T,Shimada T,Toda T,et al.Altered expression of CYP in TSOD mice:a model of type 2 diabetes and obesity[J].Xenobiotica,2009,39(12):889-902.
    [18]
    Hu N,Hu M,Duan R,et al.The increased levels of fatty acids contributed to induction of hepatic CYP3A4 activity induced by diabetes.an in vitro evidence from HepG2 cell and Fa2N-4 cell lines[J].J Pharmacol Sci,2014.Accepted.
    [19]
    Lu Y,Cederbaum AI.CYP2E1 and oxidative liver injury by alcohol[J].Free Radic Biol Med,2008,44(5):723-738.
    [20]
    Lucas D,Farez C,Bardou LG,et al.Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation[J].Fundam Clin Pharmacol,1998,12(5):553-558.
    [21]
    Wang Z,Hall SD,Maya JF,et al.Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans[J].Br J Clin Pharmacol,2003,55(1):77-85.
    [22]
    Raza H,Prabu SK,Robin MA,et al.Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats:tissue-specific variations and roles in oxidative stress[J].Diabetes,2004,53(1):185-194.
    [23]
    Baek HW,Bae SK,Lee MG,et al.Pharmacokinetics of chlorzoxazone in rats with diabetes:induction of CYP2E1 on 6-hydroxychlorzoxazone formation[J].J Pharm Sci,2006,95(11):2 452-2 462.
    [24]
    Ahn T,Yun CH,Oh DB.Tissue-specific effect of ascorbic acid supplementation on the expression of cytochrome P450 2E1 and oxidative stress in streptozotocin-induced diabetic rats[J].Toxicol Lett,2006,166(1):27-36.
    [25]
    Woodcroft KJ,Hafner MS,Novak RF.Insulin signaling in the transcriptional and posttranscriptional regulation of CYP2E1 expression[J].Hepatology,2002,35(2):263-273.
    [26]
    Matzke GR,Frye RF,Early JJ,et al.Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity[J].Pharmacotherapy,2000,20(2):182-190.
    [27]
    Kim YC,Lee AK,Lee JH,et al.Pharmacokinetics of theophylline in diabetes mellitus rats:induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation[J].Eur J Pharm Sci,2005,26(1):114-123.
    [28]
    Pass GJ,Becker W,Kluge R,et al.Effect of hyperinsulinemia and type 2 diabetes-like hyperglycemia on expression of hepatic cytochrome p450 and glutathione s-transferase isoforms in a New Zealand obese-derived mouse backcross population[J].J Pharmacol Exp Ther,2002,302(2):442-450.
    [29]
    Lewis DF.The CYP2 family:models,mutants and interactions[J].Xenobiotica,1998,28(7):617-661.
    [30]
    Sindhu RK,Koo JR,Sindhu KK,et al.Differential regulation of hepatic cytochrome P450 monooxygenases in streptozotocin-induced diabetic rats[J].Free Radic Res,2006,40(9):921-928.
    [31]
    Liu H, Liu L, Li J, et al. Combined contributions of impaired hepatic CYP2C11 and intestinal breast cancer resistance protein activities and expression to increased oral glibenclamide exposure in rats with streptozotocin-induced diabetes mellitus[J].Drug Metab Dispos,2012,40(6):1 104-1 112.
    [32]
    Kim YC,Oh EY,Kim SH,et al.Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin[J].Biopharm Drug Dispos,2006,27(2):85-92.
    [33]
    Suh YH,Kim Y,Bang JH,et al.Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats[J].J Mol Endocrinol,2005,34(2):299-315.
    [34]
    Lam JL,Jiang Y,Zhang T,et al.Expression and functional analysis of hepatic cytochromes P450,nuclear receptors,and membrane transporters in 10- and 25-week-old db/db mice[J].Drug Metab Dispos,2010,38(12):2 252-2 258.
    [35]
    Tornio A,Niemi M,Neuvonen PJ,et al.Drug interactions with oral antidiabetic agents:pharmacokinetic mechanisms and clinical implications[J].Trends Pharmacol Sci,2012,33(6):312-322.
    [36]
    Choi YH,Lee DC,Lee I,et al.Changes in metformin pharmacokinetics after intravenous and oral administration to rats with short-term and long-term diabetes induced by streptozotocin[J].J Pharm Sci,2008,97(12):5 363-5 375.
    [37]
    Marques MP, Coelho EB, Dos Santos NA, et al. Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus[J].Eur J Clin Pharmacol,2002,58(9):607-614.
    [38]
    Lennernäs H.Clinical pharmacokinetics of atorvastatin[J].Clin Pharmacokinet,2003,42(13):1 141-1 160.
    [39]
    Dostalek M, Sam WJ, Paryani KR, et al. Diabetes mellitus reduces the clearance of atorvastatin lactone:results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes[J].Clin Pharmacokinet,2012,51(9):591-606.
    [40]
    Bae SK,Kim JY,Yang SH,et al.Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin[J].Life Sci,2006,78(20):2 287-2 294.
    [41]
    Kim YC,Lee JH,Kim SH,et al.Effect of CYP3A1(23)induction on clarithromycin pharmacokinetics in rats with diabetes mellitus[J].Antimicrob Agents Chemother,2005,49(6):2 528-2 532.
    [42]
    Ahn CY,Bae SK,Bae SH,et al.Pharmacokinetics of sildenafil and its metabolite,N-desmethylsildenafil,in rats with liver cirrhosis and diabetes mellitus,alone and in combination[J].Xenobiotica,2011,41(2):164-174.
    [43]
    Ueyama J,Wang D,Kondo T,et al.Toxicity of diazinon and its metabolites increases in diabetic rats[J].Toxicol Lett,2007,170(3):229-237.
    [44]
    Anzenbacher P,Anzenbacherová E.Cytochromes P450 and metabolism of xenobiotics[J].Cell Mol Life Sci,2001,58(5/6):737-747.
    [45]
    Katabami T,Kato H,Asahina T,et al.Serum free testosterone and metabolic syndrome in Japanese men[J].Endocr J,2010,57(6):533-539.
    [46]
    Dhindsa S,Miller MG,McWhirter CL,et al.Testosterone concentrations in diabetic and nondiabetic obese men[J].Diabetes Care,2010,33(6):1 186-1 192.
    [47]
    Salonia A,Lanzi R,Scavini M,et al.Sexual function and endocrine profile in fertile women with type 1 diabetes[J].Diabetes Care,2006,29(2):312-316.
    [48]
    Kapoor D,Goodwin E,Channer KS,et al.Testosterone replacement therapy improves insulin resistance,glycaemic control,visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes[J].Eur J Endocrinol,2006,154(6):899-906.
    [49]
    Manning PJ, Allum A, Jones S, et al. The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes:a randomized controlled trial[J].Arch Intern Med,2001,161(14):1 772-1 776.
    [50]
    Kernohan AF,Sattar N,Hilditch T,et al.Effects of low-dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes[J].Clin Endocrinol(Oxf),2007,66(1):27-34.
    [51]
    Baena RM,Campoy C,Bayés R,et al.Vitamin A,retinol binding protein and lipids in type 1 diabetes mellitus[J].Eur J Clin Nutr,2002,56(1):44-50.
    [52]
    Erikstrup C,Mortensen OH,Nielsen AR,et al.Pedersen BK.RBP-to-retinol ratio,but not total RBP,is elevated in patients with type 2 diabetes[J].Diabetes Obes Metab,2009,11(3):204-212.
    [53]
    Shidfar F,Aghasi M,Vafa M,et al.Effects of combination of zinc and vitamin A supplementation on serum fasting blood sugar,insulin,apoprotein B and apoprotein A-I in patients with type I diabetes[J].Int J Food Sci Nutr,2010,61(2):182-191.
    [54]
    Zong H,Armoni M,Harel C,et al.Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance[J].Am J Physiol Endocrinol Metab,2012,302(5):E532-539.
    [55]
    Schattenberg JM,Wang Y,Singh R,et al.Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling[J].J Biol Chem,2005,280(11):9 887-9 894.
    [56]
    Carter BL, Small RE, Mandel MD, et al. Phenytoin-induced hyperglycemia[J].Am J Hosp Pharm,1981,38(10):1 508-1 512.
    [57]
    Atkin SL, Masson EA, Bodmer CW, et al. Increased insulin requirement in a patient with type 1 diabetes on rifampicin[J].Diabet Med,1993,10(4):392.
    [58]
    Obembe A.Carbamazepine-induced diabetes mellitus[J].Cent Afr J Med,1991,37(3):96-98.
    [59]
    Ueno N,Inui A,Asakawa A,et al.Erythromycin improves glycaemic control in patients with type II diabetes mellitus[J].Diabetologia,2000,43(4):411-415.
    [60]
    Fujioka K,Greenway F,Sheard J,et al.The effects of grapefruit on weight and insulin resistance:relationship to the metabolic syndrome[J].J Med Food,2006,9(1):49-54.
    [61]
    Andersson DE,Röjdmark S.Improvement of glucose tolerance by verapamil in patients with non-insulin-dependent diabetes mellitus[J].Acta Med Scand,1981,210(1/2):27-33.
    [62]
    Yamada Y,Matsuo H,Watanabe S,et al.Association of a polymorphism of CYP3A4 with type 2 diabetes mellitus[J].Int J Mol Med,2007,20(5):703-707.
    [63]
    Hoyo-Vadillo CJ,Garcia-Mena A,Valladares,et al.Association of CYP2C19 genotype with type 2 diabetes[J]. Health,2010,10:1 184-1 190.
    [64]
    Wang CP,Hung WC,Yu TH,et al.Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population:potential interaction with body mass index and family history[J].Exp Clin Endocrinol Diabetes,2010,118(6):346-352.
    [65]
    Kumashiro N,Tamura Y,Uchida T,et al.Impact of oxidative stress and peroxisome proliferator-activated receptor gamma coactivator-1alpha in hepatic insulin resistance[J].Diabetes,2008,57(8):2 083-2 091.
    [66]
    Wang XT,Zhang M,Guo HF,et al.Effect and mechanism of atorvastatin on blood glucose of mild diabetic rats[J].J China Pharm Univ(中国药科大学学报),2012,43(5):453-459.
    [67]
    He J,Gao J,Xu M,et al.PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice[J].Diabetes,2013,62(6):1 876-1 887.
    [68]
    Rys? J,Buler M,Savolainen MJ,et al.Pregnane X receptor agonists impair postprandial glucose tolerance[J].Clin Pharmacol Ther,2013,93(6):556-563.
    [69]
    Dong B,Saha PK,Huang W,et al.Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease[J].Proc Natl Acad Sci U S A,2009,106(44):18 831-18 836.
    [70]
    Roman RJ.P-450 metabolites of arachidonic acid in the control of cardiovascular function[J].Physiol Rev,2002,82(1):131-185.
    [71]
    Capdevila J, Chacos N, Werringloer J, et al. Liver microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid[J].Proc Natl Acad Sci U S A,1981,78(9):5 362-5 366.
    [72]
    Morrison AR,Pascoe N.Metabolism of arachidonate through NADPH-dependent oxygenase of renal cortex[J].Proc Natl Acad Sci U S A,1981,78(12):7 375-7 378.
    [73]
    Singh H,Cheng J,Deng H,et al.Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension[J].Hypertension,2007,50(1):123-129.
    [74]
    Kroetz DL, Xu F. Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation[J].Annu Rev Pharmacol Toxicol,2005,45:413-438.
    • Related Articles

Catalog

    Get Citation
    PDF
    XML
    Article views (1627) PDF downloads (2426) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：297223

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return